Mebendazole
Sponsors
Johns Hopkins Bloomberg School of Public Health, DBL -Institute for Health Research and Development, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., McGill University Health Centre/Research Institute of the McGill University Health Centre, University Ghent
Conditions
AmoebiasisAnaplastic AstrocytomaAnaplastic OligodendrogliomaAncylostoma CaninumAncylostoma CeylanicumAncylostoma DuodenalAnemiaAscaris Lumbricoides
Phase 1
Mebendazole in Newly Diagnosed High-Grade Glioma Patients Receiving Temozolomide
CompletedNCT01729260
Start: 2013-04-04End: 2021-04-16Updated: 2021-05-07
A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
CompletedNCT01837862
Start: 2013-10-22End: 2024-04-30Target: 36Updated: 2024-07-05
Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
CompletedNCT02644291
Start: 2016-05-31End: 2022-06-09Updated: 2022-06-23
Phase 2
Efficacy and Safety of a New Chewable Versus the Swallowable Tablet of Mebendazole Against Hookworm
CompletedNCT03995680
Start: 2019-07-12End: 2019-10-09Updated: 2020-07-20
Efficacy and Safety of Oxantel Pamoate in Children Infected With Trichuris Trichiura
CompletedNCT06720259
Start: 2025-04-16End: 2025-05-28Updated: 2025-06-08
Phase 3
Severe Anemia Treatment Trials, Pakistan
CompletedNCT00116493
Start: 2004-04-30End: 2007-05-31Updated: 2012-04-09
A Safety Study of Mebendazole in Children 2 to 10 Years of Age
CompletedNCT01173562
Start: 2010-02-28End: 2010-03-31Updated: 2014-03-12
A Study to Assess the Efficacy and Safety of Mebendazole for the Treatment of Helminth Infections in Pediatric Participants
CompletedNCT02034162
Start: 2014-12-31End: 2015-09-30Updated: 2016-11-04
Mebendazole as Adjuvant Treatment for Colon Cancer
RecruitingNCT03925662
Start: 2019-04-01End: 2028-12-31Target: 40Updated: 2019-04-24
Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections
Enrolling by invitationNCT06736691
Start: 2025-11-25End: 2026-07-31Target: 315Updated: 2026-01-07
Phase 4
The Effect of a Deworming Intervention to Improve Early Childhood Growth and Development in Resource-poor Areas
CompletedNCT01314937
Start: 2011-09-30End: 2013-07-31Target: 1760Updated: 2014-08-26
Monitoring the Efficacy of Anthelmintics for the Treatment of Soil Transmitted Helminths P2
CompletedNCT01379326
Start: 2011-12-31End: 2012-12-31Updated: 2014-12-05
Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population
CompletedNCT02385058
Start: 2005-10-31End: 2006-01-31Updated: 2015-04-14
Mebendazole Study Against Hookworm Infections in Children and Adolescents in Ghana
WithdrawnNCT03261596
Start: 2017-09-30End: 2017-12-31Updated: 2017-11-17
Triple Combinations Against Hookworm Infections in Lao
CompletedNCT03278431
Start: 2017-09-27End: 2017-12-01Updated: 2018-05-08
Unknown Phase
Safety and Efficacy of Drug Combinations Against Trichuris Trichiura
CompletedNCT01050452
Start: 2007-10-31End: 2009-08-31Target: 750Updated: 2010-01-15
To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma.
NCT04443049
Start: 2020-07-10End: 2022-06-19Target: 170Updated: 2021-10-05
Possible Efficacy and Safety of Mebendazole in Patients With Ulcerative Colitis Treated With Mesalamine
RecruitingNCT06335160
Start: 2024-04-20End: 2026-05-01Target: 46Updated: 2026-02-06